By Peter A. Netland, MD, PhD
    Subspecialty Day 2011: Glaucoma

    Neovascular glaucoma (NVG) is a secondary glaucoma with numerous causes. In this presentation, Dr. Peter Netland describes how treatment depends on the etiology and stage of the disease, focusing first on the underlying cause followed by treatment of the secondary glaucoma. Primary therapies, especially in stage I NVG, include intravitreal anti-VEGF injection such as bevacizumab, panretinal photocoagulation (PRP), and endolaser. Patients with stage II or III NVG generally require ancillary treatment of glaucoma with medication and often trabeculectomy with MMC or a glaucoma drainage implant.